Results 161 to 170 of about 71,302 (258)

Revealing crossed-beam energy transfer as the origin of asymmetric backscattering in hohlraums. [PDF]

open access: yesNat Commun
Hao L   +26 more
europepmc   +1 more source

Step‐Ladder Bioprinting to Align Collagen Fibers for Anisotropic Tissue Fabrication

open access: yesSmall, Volume 22, Issue 13, 3 March 2026.
The step‐ladder printing platform includes successive segments of channels with varying widths in a custom barrel design. This design allows for improved anisotropy of collagen fibers during extrusion. To demonstrate its effectiveness, corneal constructs with high transparency and shape fidelity, as well as articular cartilage constructs, displaying ...
Ilayda Namli   +8 more
wiley   +1 more source

Effects of Pyrolysis Control Parameters on the Structural Properties of Biomass‐Derived Activated Carbon Materials and Their Energy Applications

open access: yesThe Chemical Record, Volume 26, Issue 3, March 2026.
Tubular pyrolysis synthesis is a widespread method to produce activated carbons (ACs). This review focuses on the different controlling parameters of the tubular pyrolysis synthesis method and their influence on the performance of synthesized ACs, thereby considering both experimental aspects and the use of plant‐based biomasses (PBBs) as feedstock ...
Meenal Gupta   +6 more
wiley   +1 more source

The Functional Delta Method for Deriving Asymptotic Distributions

open access: yesWIREs Computational Statistics, Volume 18, Issue 1, March 2026.
The distribution of the scaled difference between the plug‐in estimator Tθ̂n$$ T\left({\hat{\boldsymbol{\theta}}}_n\right) $$ and the true parameter Tθ0$$ T\left({\boldsymbol{\theta}}_0\right) $$ is approximated by the distribution of the scaled difference between θ̂n$$ {\hat{\boldsymbol{\theta}}}_n $$ and θ0$$ {\boldsymbol{\theta}}_0 $$ and a ...
Eric Beutner
wiley   +1 more source

Drug Product Development of Lipid Nanoparticle‐Based mRNA Therapeutics and Vaccines

open access: yesWIREs Nanomedicine and Nanobiotechnology, Volume 18, Issue 2, March/April 2026.
Overview of the development path from an mRNA–lipid nanoparticle (LNP) concept to a licensed drug product, covering LNP design, manufacturing process development, formulation, and analytical characterization. ABSTRACT Lipid nanoparticles (LNP) are currently the most relevant non‐viral delivery systems for mRNA and occasionally for smaller nucleic acids
Gideon Kersten   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy